Antimicrobial Susceptibility of Multidrug-Resistant Acinetobacter baumanii in a Teaching Hospital: A Two-Year Observation


Multidrug-resistant (MDR) Acinetobacter baumanii (A. baumanii) caused hospital acquired infection, typically in critical-ill patients with medical devices. This is a retrospective descriptive study on epidemiology and microbiology data to determine the antimicrobial susceptibility pattern of MDR-Acinetobacter baumanii isolates from a teaching hospital in Tangerang, Indonesia from Januari 2013 to December 2014. A total of 84 A. baumanii were collected. Patients suffering from respiratory tract infection had the highest number (41.7%) of A. baumanii isolate. There were 39 (46.6%) patients admitted in critical care. A. baumanii isolates in this study mostly were multidrug-resistant organisms with low susceptibility level to 11 antibiotic tested, 44% - 69% in 2013 and 26% - 67% in 2014. A high susceptibility level was observed to amikacin (80% and 79% in 2013, 2014 consecutively) and trimethoprim-sulfamethoxazole (73% and 72% in 2013, 2014 consecutively). A. baumanii is a hospital acquired pathogen in critically-ill patients. The susceptibility pattern of this study result showed MDR organism. There was a sharp decrease of susceptibility in all antibiotics studied from 2013 to 2014 except amikacin and trimethoprim-sulfamethoxazole.

Share and Cite:

 , C. , Wiwing, V. and Lugito, N. (2015) Antimicrobial Susceptibility of Multidrug-Resistant Acinetobacter baumanii in a Teaching Hospital: A Two-Year Observation. Open Journal of Medical Microbiology, 5, 85-89. doi: 10.4236/ojmm.2015.52010.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Munoz-Price, L.S., and Weinsten, R.A. (2008) Acinetobacter Infection. New England Journal of Medicine, 358, 1271-1288.
[2] Visca, P., Seifert, H. and Towner, K.J. (2011) Acinetobacter Infection—An Emerging Threat to Human Health. IUBMB Life, 63, 1048-1054.
[3] Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P. and Edmond, M.B. (2004) Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24, 178 Cases from a Prospective Nationwide Surveillance Study. Clinical Infectious Diseases, 39, 309-317.
[4] Abbo, A., Carmeli, Y., Navon-Venezia, S., Seigman-Igra, Y. and Schwaber, M.J. (2007) Impact of Multidrug-Resistant Acinetobacter baumanii on Clinical Outcomes. European Journal of Clinical Microbiology and Infectious Diseases, 26, 793-800.
[5] Cisneros, J.M. and Rodriguez-Bano, J. (2002) Nosocomial Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Features, and Treatment. Clinical Microbiology and Infection, 8, 687-693.
[6] Dijkshoorn, L., Nemec, A. and Harald, S. (2007) An Increasing Threat in Hospitals: Multidrug-Resistant Acinetobacter baumannii. Nature, 5, 939-949.
[7] Perez, F., Hujer, A.M., Hujer, K.M., Decker, B.K., Rather, P.N. and Bonomo, R.A. (2007) Global Challenge of Multidrug-Resistant Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy, 51, 3471-3484.
[8] Gonlugur, U., Bakici, M.Z., Akkurt, I. and Efeoglu, T. (2004) Antibiotic Susceptibility Patterns among Respiratory Isolates of Gram-Negative Bacilli in a Turkish University Hospital. BMC Microbiology, 4, 1471-2180.
[9] Clinical and Laboratory Standard Institute (2002) Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Second Informational Supplement. M100-S22, 32, 64-65.
[10] Howard, A., Donoghue, M.O., Feeney, A. and Sleator, R.D. (2010) Acinetobacter baumannii: An Emerging Opportunistic Pathogen. Virulence, 3, 243-250.
[11] Dent, L.L., Marshal, D.R., Pratap, S. and Hulette, R.B. (2010) Multidrug Resistant Acinetobacter baumanii: A Descriptive Study in a City Hospital. BMC Infectious Diseases, 10, 196, 1-7.
[12] Khan, M.A., Mahomed, M.F., Ashshi, A.M. and Faiz, A. (2012) Drug Resistance Patterns of Acinetobacter baumanii in Makkah, Saudi Arabia. Pakistan Journal of Medical Research, 51, 127-131.
[13] Joshi, S.G., Litake, G.M., Satpute, M.G., Telang, N.V., Ghole V.S. and Niphadkar K.B. (2006) Clinical and Demographic Features of Infection Caused by Acinetobacter Species. Indian Journal of Medical Sciences, 60, 351-360.
[14] Hsueh, P.R., Teng, L.J., Chen, C.Y., Chen, W.H., Ho, S.W. and Luh, K.T. (2002) Pandrug-Resistant Acinetobacter baumanii Causing Nosocomial Infections in a University Hospital, Taiwan. Emerging Infectious Diseases, 8, 827-832.
[15] Türkpglu, M.A. and Iskit, T.A. (2008) Ventilator Associated Pneumonia Caused by High Risk Microorganisms: A Matched Case Control Study. TuberkToraks, 56, 139-149.
[16] Dizbay, M., Tunccan, O.G., Ergur-Sezer, B. and Hizel, K. (2010) Nosocomial Imipenem-Resistant Acinetobacter baumanii Infections: Epidemiology and Risk Factors. Scandinavian Journal of Infectious Diseases, 42, 741-746.
[17] Mahajan, G., Sheemar, S. and Chopra, S. (2011) Carbapenem Resistance and Phenotypic Detection of Carbapenemases in Clinical Isolates of Acinetobacter baumanii. Indian Journal of Medical Sciences, 65, 18-25.
[18] Maragakis, L.L. and Perl, T.M. (2008) Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options. Clinical Infectious Diseases, 46, 1254-1259.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.